Orgenesis Inc. (ORGS) - EV/EBITDA Multiple
Orgenesis Inc. (ORGS) develops IT solutions for cell therapy. This chart of the asset's value on GURU.Markets confirms the low cyclicality of the business, where the niche's macro-resilience depends only partially on the pace of commercial deal closures. The current indicator is . Stability is driven by the sovereign development cycle of innovative research, transforming the sector into a defensive asset. Demand here is dictated by patients' biological needs and the speed of implementing new treatment protocols.
ORGS (orgenesis.com): analytical breakdowns and indicator data
- market price and analyst price targets:
- market capitalization indicators:
- issuer book value statistics:
- debt and liquidity details:
Total Debt to Capital Orgenesis Inc.|ORGS - Long-Term Liabilities to Capital|Short-Term Debt to Equity Orgenesis|ORGS - Company Total Debt Obligations|Debts to Book Capitalization Orgenesis Corporation|ORGS - Long-Term Debt Volume|Company Short-Term Debt Orgenesis|Quick Liquidity Indicator orgenesis.com
- financial results and valuation multiples details:
ORGS - Final Profit|Projected Future Earnings Orgenesis Inc.|ORGS - Business Payback Period|Future Price to Earnings Orgenesis Inc.|ORGS - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Orgenesis Corporation|ORGS - Operating profit before deduction of amortization|Net earnings per share for the last 12 months Orgenesis|ORGS - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months orgenesis.com|ORGS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Orgenesis Inc.
Comprehensive company analysis:Orgenesis Corp ORGS
The analyst assesses the resilience of Orgenesis Inc. (ORGS) to market shocks through its ability to generate cash flow to service its obligations. The scaling efficiency of cellular technologies and partnerships with biobanks directly impact the business's operating margins. This enterprise value-to-EBITDA ratio compares the total value of assets and debts against EBITDA, allowing the investor to determine the company's fair value and the risk of overpayment.
Analysis of competing companies
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|Business Value to Operating Income Before Depreciation DOCS|HealthEquity, Inc. - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple waystar.com (WAY)|CRVL: EV/EBITDA Multiple|Company Value to EBITDA Privia Health Group, Inc. (PRVA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Huron Consulting|Enterprise Value to Operating Income Before Depreciation CERT (Certara Software)|EV/EBITDA Multiple OMCL|GDRX - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Schrödinger SDGR|Total Company Value to Operating Income Before Depreciation Ratio Phreesia Inc (PHR)|Omada Health Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Evolent Corp EVH|HealthStream, Inc. (HSTM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|DH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio CCSI|AGL: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ABSI|Total Company Value to Operating Income Before Depreciation Ratio So-Young Corp|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization National Research NRC|SPOK: Enterprise Value to Operating Income Before Depreciation|OptimizeRx - EV/EBITDA Multiple|TruBridge Inc (TBRG) - Enterprise Value to EBITDA Ratio|SLP (Simulations Plus Corp) - Enterprise Value to EBITDA Ratio|SOPH - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Health Catalyst, Inc.|Company Value to EBITDA CareCloud Corp CCLD|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Research Solutions, Inc. (RSSS)|DLHC (dlhcorp.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ONMD (OneMedNet)|Enterprise Value to EBITDA Multiple Scienture Corp|HCTI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio iSpecimen Inc. ISPC|BFRG: EV/EBITDA Multiple|WORX - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MSPR|ICCT (iCoreConnect Corp) - Enterprise Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio MEDS (TRxADE HEALTH, Inc.)|RCM (r1rcm.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sharecare SHCR|STRM - Enterprise Value to EBITDA Ratio|Syra Health Corporation - EV/EBITDA Multiple|Company Value to EBITDA Apollo Medical Holdings|MODN: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation NXGN
